Live from the NIH registry
Studies recruiting near South Lyon right now
Top 25 of 1,319 recruiting studies, sorted by proximity — each links to its official registry page
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
C.S. Mott Children's Hospital — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Nationwide Children's Hospital
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
University of Michigan Medical School — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
C S Mott Children's Hospital — Ann Arbor, Michigan (13.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Thrombocythemia, Essential, Primary Myelofibrosis
Phase 3
Interventional 400 participants sought
University of Michigan ( Site 6000) — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Detroit Clinical Research Center — Farmington Hills, Michigan (14.1 mi)
· Sponsor: Regeneron Pharmaceuticals
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Relay Therapeutics, Inc.
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Kura Oncology, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Trinity Health IHA Medical Group Hematology Oncology - Brighton — Brighton, Michigan (8.0 mi)
· Sponsor: SWOG Cancer Research Network
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Age-Related Macular Degeneration, Geographic Atrophy
N/A
Interventional 125 participants sought
Oakland Ophthalmic Surgery — Birmingham, Michigan (23.2 mi)
· Sponsor: VisionCare, Inc.
Cryoablation Effects on Acute and Chronic Pain After Thoracotomy and Thoracoscopy
Pain, Postoperative, Intrathoracic Procedure
N/A
Interventional 80 participants sought
University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: University of Michigan
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Phase 1, Phase 2
Interventional 39 participants sought
University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: Tr1X, Inc.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Ann Arbor, Michigan (13.5 mi)
· Sponsor: AstraZeneca
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Hypertension, Pulmonary, Lung Diseases, Interstitial
Phase 2
Interventional 25 participants sought
Allen Park — Allen Park, Michigan (26.6 mi)
· Sponsor: Tectonic Operating Company, Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Associated Retinal Consultants PC — Royal Oak, Michigan (26.0 mi)
· Sponsor: Genentech, Inc.
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Ann Arbor, Michigan (13.5 mi)
· Sponsor: AstraZeneca
Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients
Inflammatory Bowel Diseases
N/A
Interventional 40 participants sought
University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: University of Michigan
Adversity, Brain and Opioid Use Study
Opioid Use Disorder, Healthy
N/A
Interventional 185 participants sought
University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: University of Michigan
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
Allergic Reactions
Phase 4
Interventional 600 participants sought
University Of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: ARS Pharmaceuticals, Inc.
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
Michigan Institute of Urology, PC — Troy, Michigan (27.5 mi)
· Sponsor: Pfizer
Access Sheath and Stent Trial
Kidney Stone, Ureteral Stone
N/A
Interventional 184 participants sought
University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: University of Michigan
Treatment of the Biceps With Concomitant Supraspinatus Tears
Supraspinatus Tear
N/A
Interventional 180 participants sought
Sports Medicine and Shoulder Surgery, University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: La Tour Hospital
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
Huron Gastroenterology Associates, P.C. — Ypsilanti, Michigan (15.4 mi)
· Sponsor: Takeda
Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival
Peripheral Intravenous Vein Catheter Phlebitis, Intravenous Infection
N/A
Interventional 360 participants sought
Beaumont Hospital - Royal Oak — Royal Oak, Michigan (26.0 mi)
· Sponsor: Corewell Health East
Move and Snooze: Adding Insomnia Treatment to an Exercise Program to Improve Pain Outcomes in Older Adults With Knee Osteoarthritis
Knee Osteoarthritis, Insomnia
N/A
Interventional 288 participants sought
University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: University of Michigan
BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS
AML, Adult Recurrent, ALL, Recurrent, Adult
Phase 1, Phase 2
Interventional 38 participants sought
University of Michigan — Ann Arbor, Michigan (13.5 mi)
· Sponsor: BlueSphere Bio, Inc